Chronic HCV Infection: Clinical Advances and Eradication Perspectives

Chronic HCV Infection: Clinical Advances and Eradication Perspectives

EMERGING INFECTIOUS DISEASES--EPIDEMIOLOGY

Hepatitis C virus (HCV) chronic infection can determine liver fibrosis, cirrhosis and hepatocellular carcinoma, as well as several extra-hepatic manifestations (i.e., mixed cryoglobulinemia, metabolic syndrome, kidney disease, etc.). HCV infection is asymptomatic until severe stages of disease, thus screening policy in the general population and in specific risk categories is necessary to allow for timely intervention. Despite a high sustained virological response by direct-acting antiviral drugs, a limited percentage of treated subject failed therapy according to resistance associated substitution carried on viral isolates and comorbidities in infected patients. Therefore, tailored therapy is required to cure HCV infection. Failure to comply with these conditions may impair success of HCV eradication expected by 2030. This Special Issue aims to discuss eradication perspectives related to therapy efficacy in patients with chronic diseases, developments in diagnostic procedures and improvements in screening policy.

Liberto, Maria Carla (editor)
Marascio, Nadia (editor)

https://directory.doabooks.org/handle/20.500.12854/79675

MDPI - Multidisciplinary Digital Publishing Institute

2022

Sulistiorini

https://creativecommons.org/licenses/by/4.0/

1. Jur-Shan Cheng, Yu-Sheng Lin, Jing-Hong Hu, Ming-Yu Chang, Hsin-Ping Ku, Rong-Nan
Chien and Ming-Ling Chang
Impact of Interferon-Based Therapy on Hepatitis C-Associated Rheumatic Diseases: A
Nationwide Population-Based
Cohort Study
2. Nadia Marascio, Angela Costantino, Stefania Taffon, Alessandra Lo Presti, Michele Equestre,
Roberto Bruni, Giulio Pisani, Giorgio Settimo Barreca, Angela Quirino, Enrico Maria
Trecarichi, Chiara Costa, Maria Mazzitelli, Francesca Serapide, Giovanni Matera, Carlo Torti,
Maria Carla Liberto and Anna Rita Ciccaglione
Phylogenetic and Molecular Analyses of More Prevalent HCV1b Subtype in the Calabria
Region, Southern Italy
3. Mira Florea, Teodora Serban, George Razvan Tirpe, Alexandru Tirpe and Monica
Lupsor-Platon
Noninvasive Assessment of Hepatitis C Virus Infected Patients Using Vibration-Controlled Transient Elastography
4. Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Anna Parfieniuk-Kowerda, Ewa Janczewska,
Dorota Dybowska, Małgorzata Pawłowska, Waldemar Halota, Włodzimierz Mazur, Beata
Lorenc, Justyna Janocha-Litwin, Krzysztof Simon, Anna Piekarska, Hanna Berak, Jakub
Klapaczy ´nski, Piotr Stępień, Barbara Sobala-Szczygieł, Jolanta Citko, Łukasz Socha,
Magdalena Tudrujek-Zdunek, Krzysztof Tomasiewicz, Marek Sitko, Beata Dobracka, Rafał
Krygier, Jolanta Białkowska-Warzecha, Łukasz Laurans and Robert Flisiak
Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics
5. Maria Pokorska- ´ Spiewak, Anna Dobrzeniecka, Małgorzata Aniszewska and Magdalena
Marczy´ nska
Real-Life Experience with Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C
Virus Infection with Genotypes 1 and 4 in Children Aged 12 to 17 Years—Results of the POLAC Project

Pdf

English

Textbooks

DOI
10.3390/books978-3-0365-3362-9